Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aniline Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106349295B reveals mild reduction method. Offers cost reduction in pharma intermediate manufacturing and high-purity aniline derivatives.